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1. Introduction
 Malaria is a major health problem in India and contributes 
significantly to the overall malaria burden in Southeast 
Asia. The National Vector Borne Disease Control Program 
of India reported ~1.6 million cases and ~1 100 malaria 
deaths in 2009. Some experts argue that this is a serious 
underestimation and that the actual number of malaria 
cases per year is likely between 9 and 50 times greater, with 
an approximate 13-fold underestimation of malaria-related 
mortality[1,2]. Complexities in the life cycle of parasite, 
environmental interactions, high cost of anti-malarial 
drugs for people living in endemic countries, migration of 
population between endemic and non-endemic areas and 
resistance of Plasmodium falciparum (P. falciparum) to 
chloroquine, mefloquine and sulfadoxine-pyrimethamine 
including artemisinin combined therapies, has fuelled 
the burden of this protozoal infection further more[3-6]. 
Ever-increasing resistance of malarial parasites to the 
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commonly available anti-malarial drugs necessitated the 
search for new drugs, especially from plants. Traditionally 
used medicinal plants have played important role in malaria 
treatment across the globe[7-9]. We investigated the plants 
selected on the basis of their traditional usage by comparing 
the disease symptomatology and recommended use from the 
texts of Ayurveda (Indian System of Medicine) and used them 
in the forms as used traditionally (water extracts and herb 
powders) as far as possible. We screened aqueous extracts 
of two plants Holarrhena antidysentrica (H. antidysentrica) 
(Kutaja) and Azadirachta indica (A. indica) (Neemb) for their 
antiplasmodial potential in Plasmodium berghei (P. berghei) 
infected mice. 
     
2. Materials and methods
2.1. Plant materials 
  The plants selected viz. A. indica (leaves, stem) and H. 
antidysentrica (bark) were collected from Gujarat state of 
India. The plant species were taxonomically identified and 
confirmed using morphological and anatomical technique. 
They were authenticated at the Botanical Survey of India, 
Pune and voucher specimens were deposited.
 
2.2. Preparation of samples
  Aqueous extracts were prepared from 500 g of fresh raw 
material of plant parts in a round bottom flask. This mixture 
was heated in stainless steel extraction vessel under reflux 
with stirrer for three cycles with water. After each cycle, 
water was added to replenish the remaining volume. The 
extracts were dried in a rotatory evaporator under vacuum 
at temperature not exceeding 35 曟. The dry extracts of all 
samples were stored in air-tight sample containers at 4 曟 
until use. For administration to the animals, the aqueous 
extracts were diluted in distilled water and vortex to get a 
clear solution. 
2.3. Pharmacodynamic evaluation: in vivo antimalarial 
efficacy testing in P. berghei infected mice
  The protocol for animal studies was approved by the 
Institutional ethical committee of the Tata Institute of 
Fundamental Research, (TIFR). The protocol was designed 
on the basis of “Peters four day suppressive test” described 
by Peters et al[10,11]. The lethal strain of P. berghei was used 
for the experiments. In-house bred mycoplasma free male 
Swiss mice (weighing around 30 g each) were infected by 
intraperitoneal inoculation of donor mouse blood diluted in 
acid citrate dextrose (ACD) buffer containing approximately 
10
6 P. berghei infected RBCs on day ’0’. The mice were 
randomly divided into various groups (n=8 per group) as 
depicted in Table 1. Starting from day ’0’ till day ’3’ post 
infection, the different groups were given the assigned 
treatment (or no treatment for control) by oral gavage. The 
total volume administered was 400 毺L. On fourth day, the 
blood was withdrawn from tail vein and the blood smears 
were prepared. Blood smears were fixed with methanol and 
stained with Giemsa stain and the parasites were counted. 
Parasitemia is the quantitative content of parasites in the 
blood. Parasitemia was reported as percentage parasitemia 
after counting 250 RBCs from each slide. Activity of the 
treatment groups was calculated by the following formula 
suggested in the standard protocol by Fidock et al[12].
Activity = 100-(mean parasitemia of treated group/mean 
parasitemia of control group)暳 100
The animals in all the groups were also monitored for their 
survival.
Table 1
Summary of the different groups and their treatment regimen used for 
in vivo antimalarial efficacy studies.
Group (n=8) Infection Treatment
Full dose of H. antidysenterica (HA) + 1  0 0 0  m g / d  o f  H . 
antidysenterica
Minimized dose of 
H. antidysenterica (HA)
+ 2 0 0  m g / d  o f  H . 
antidysenterica
Full dose of A. indica (AI) + 1 000 mg/d of A. indica
Minimized dose of A. indica (AI) + 200 mg/d of A. indica
Chloroquine + 5  m g / k g / d  o f 
Chloroquine[13]
Control + No treatment
2.4. Statistical analysis
Data was expressed as mean暲SD. and parasitemia of the 
different groups were statistically assessed by unpaired 
t-test using Graphpad Instat Demo version. Differences were 
considered significant at P<0.05.
1. % Parasitemia of infected mice was calculated:
Number of infected red blood cell
Total red blood cell
伊100=% parasitemia
2. % Activity of the treatment groups was calculated by the 
following formula suggested in the standard protocol by 
Fidock et al[12]
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% Activity = 100-(mean parasitemia of treated group/mean 
parasitemia of control group)暳 100
3. Percent suppression of parasitemia was calculated:
Parasitemia of control-parasitemia of test/ Parasitemia of 
control 暳100
4. Number of survival days and % survival was calculated.
3. Results
  The % parasitemia was calculated till 50% of animals in 
control survived, which was Day 9. The mean % parasitemia 
of the mice in each group was as mentioned in Table 2. It 
was observed that the % parasitemia increased gradually 
in all the groups,  with maximum in control group (Day 
3-35, Day 9-46.98) and minimum in Chloroquine arm (Day 
3-14.06, Day 9-19.92) (Figure 1).
Table 2
The mean % parasitemia seen in each group was as follows. 
Group Day 3 Day 4 Day 5 Day 6 Day 7 Day 9
Full dose of 
H. antidysenterica
19.58 20.69 26.41 31.68 32.29 33.10
Minimized dose of 
H. antidysenterica
15.54 16.16 16.44 19.23 19.58 20.38
Full dose of A. indica 16.10 16.91 23.73 25.87 25.65 26.35
Minimized dose of A. indica 16.55 17.17 21.69 24.31 24.52 25.20
Chloroquine 14.06 16.22 17.12 18.04 18.65 19.92
Control 35.00 36.31 37.90 45.46 46.26 46.98
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Figure 1. % parasitemia in the groups from day 3 to day 9. 
  The % parasitemia was compared using Mann-Whitney 
U test depicting that all test groups exhibited reduction 
in parasitemia as compared to control (P-value<0.002 for 
all groups). While it was observed that the reduction in H. 
antidysentrica minimized dose group and A. indica group was 
comparable to Chloroquine (Figure 2).
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Figure 2.  % parasitemia . 
It was assessed using Mann-Whitney U test, the parasitemia reduction 
in H. antidysentrica minimized dose group and A. indica group 
was comparable to Chloroquine. While all the test groups showed 
statistically significant reduction as compared to distilled water (P 
value < 0.002 for all groups). 
HA full: H. antidysentrica full dose Group 1, HA mini: H. antidysentrica 
minimized dose Group 2, AI full: A. indica full dose Group 3, AI mini: 
A. indica minimized dose Group 4, CHQ: Chloroquine, DW: Distilled 
water). 
    % activity was calculated using the formula as mentioned 
above (Figure 3). It was observed that minimized dose 
HA showed comparable activity to Chloroquine. Percent 
suppression in these 2 groups was similar too. In both these 
groups 3 animals survied till Day 10, while % survival was 
highest in minimized dose HA amongst the test groups 
followed by mimimized dose AI, and full dose AI (Table 3 
and 4).
Table 3
In-vivo anti-malarial activity of various formulations in P. berghei 
infected mice (n=8).
Treatment group Average 
%parasitemia暲SD
%activity No. of
survivals
(n=8, t=18 d)3rd day 9th day 3rd day 9th day
Full dose of 
H. antidysenterica
19.6暲2.8 33.1暲4.8 44 30 0
Minimized dose of
H. antidysenterica
15.5暲4.1 20.4暲3.3 56 57 3
Full dose of 
A. indica
16.1暲2.3 26.4暲2.3 54 44 2
Minimized dose of
A. indica
16.5暲2.3 25.2暲3.0 53 47 2
Chloroquine 14.1暲3.3 19.9暲2.3 60 58 3
Control 35.0暲4.7 47.0暲9.6   0   0 0
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Table 4
In-vivo anti-malarial activity of plant extracts (H. antidyesntrica and 
A. indica) against P. berghei infected Swiss albino mice.
Plant extract Dose Mean 暲 SD
parasitemia 
(%)
Percent
suppression 
of 
parasitemia
% Survival 
of animal on 
day 10
H. antidyesntrica 1 000 mg/d 27.3暲6.0 34  13
H. antidyesntrica 200 mg/d 17.9暲2.1 57  63
A. indica 1 000 mg/d 22.4暲4.7 46  38
A. indica 200 mg/d 21.6暲3.8 48  50
Chloroquine 5 mg/kg/d 17.3暲2.0 58 100
Distilled water - 41.3暲5.5 - -
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Figure 3. % activity in all the treatment groups compared to the 
controls.
The survival analysis was performed using ANOVA to 
compare the 2 dose levels of drugs with chloroquine and 
control group. Low dose was found to be more efficacious 
than full dose of test sample, when compared with control 
(P-value <0.000 1) (Figure 4).
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Figure 4. Survival proportions of all the groups.
4. Discussion
  In this study, we have found that the both aqueous extracts 
of H. antidysentrica and A. indica demonstrated the anti 
plasmodial property. The parasitemia was reduced in both 
the dose ranges for these extracts as compared to control (P 
value<0.002). Although H. antidysentrica minimized dose 
and A. indica group were comparable to Chloroquine for 
lowering parasitemia and for survival. A. indica minimized 
dose showed slightly better percent suppression of 
parasitemia and % survival than its full dose. The present 
investigation thus demonstrated the anti-plasmodial effects 
of H. antidysentrica and A. indica which are two most 
commonly used medicinal plants in Ayurved for treatment of 
fever. 
  The interest in screening of compounds of natural origin 
or of ethno pharmacological background to develop 
antimalarial therapy has increased in last few years. Many 
plants compounds and extracts used traditionally have 
exhibited promising anti-plasmodial activity. In present 
study we used 1 000 mg/d and 200 mg/d dose calculated 
for weight of mice. We used aqueous extracts and water 
as a solvent to mimic the traditional use of these plant 
compounds. Percent parasitemia of infected mice and 
percent activity of the treatment groups were calculated 
as per the formula mentioned by Fidock et al[12]. Percent 
suppression of parasitemia was assessed using the formula 
by Obih et al[14]. Statistical significant reduction in percent 
parasitemia of all the test groups was found when compared 
with the control using Mann Whitney U test (P value<0.002). 
The reduction was comparable to Chloroquine group for 
H.antidysentrica minimized dose group and A. indica full 
dose. The numbers of survival till day 18 were observed in 
H. antidysentrica minimized dose group, A. indica full and 
minimized dose group and Chloroquine indicating the effect 
of treatment groups on the survival of infected mice. H. 
antidysentrica minimized dose exhibited 57% suppression of 
parasitemia followed by A. indica minimized dose (48%) and 
A. indica full dose (46%) in the treatment groups. The survival 
was 63% in H. antidysentrica minimized dose followed by 
the A. indica minimized dose (50%). It can be noted that 
both the minimized doses exhibited better parasitemia 
suppression and survival as compared to full dose. Recently 
a study published by Verma et al screened the 10, 20 & 30 
mg/kg of chloroform extract  of the H. antidysentrica in P. 
berghei infected mice, which demonstrated 73.2% parasite 
inhibition at 30 mg/kg[15]. There are very few studies for H. 
antidysentrica including the one mentioned above published 
recently. A. indica fractions have shown activities superior 
to chloroquine in-vitro[16,17]. Yet there were very few studies 
with aqueous extracts of A. indica and its activity in a 
mouse model. Many other Indian medicinal plants have 
been examined in-vitro against  P. falciparum, of which 
ethanol extracts Holarrhena pubescens, Pongamia pinnata, 
Plumbago zeylanica have exhibited IC50 of 28 毺g/mL, 25 毺
g/mL and 17 毺g/mL[18]. The IC50 of various solvent extracts 
of Carica papaya, Ocimum sanctum, Adhatoda vasica, etc 
indicated anti-plasmodial activity of the traditionally used 
Jadhav Priyanka et al./Asian Pacific Journal of Tropical Medicine (2013)520-524524
medicinal plants[19]. Ellagic acid which is an important 
chemical constituent of Punica granatum, exhibited 
high in-vitro and in-vivo antiplasmodial properties 
and synergistic activity with chloroquine, atovaquone, 
mefloquine and artesunate[20].
  Other traditional medicinal plants from Kenya have also 
shown low IC50 values, high percent suppression and low 
cytotoxicity, thus indicating potential source for anti-
plasmodial agents[21]. A. indica along with other Sudanese 
medicinal plants exhibited highly potent antimalarial 
property[22]. Thus it is evident that traditionally used 
medicinal plants have potential and must be explored for 
novel drug candidate. 
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